Skip to main content
Erschienen in: Digestive Diseases and Sciences 7/2016

10.02.2016 | Editorial

SEMS for Palliation of Malignant Colonic Obstruction: Why SEMi Available Is Not Good Enough

verfasst von: Christian P. Selinger

Erschienen in: Digestive Diseases and Sciences | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Excerpt

In the past, treatment for acute colonic obstruction was emergency surgery with ostomy. Over the last two decades, the availability of colonic self-expanding metal stents (SEMSs) has provided new treatment options and therapeutic paradigms for malignant obstruction of the colon. In the setting of incurable colorectal cancer (CRC) complicated by colonic obstruction, colonic SEMS placement is the preferred option for palliation of patients not receiving antiangiogenic therapy [1]. …
Literatur
1.
Zurück zum Zitat Zhao XD, Cai BB, Cao RS, Shi RH. Palliative treatment for incurable malignant colorectal obstructions: a meta-analysis. World J Gastroenterol. 2013;19:5565–5574.CrossRefPubMedPubMedCentral Zhao XD, Cai BB, Cao RS, Shi RH. Palliative treatment for incurable malignant colorectal obstructions: a meta-analysis. World J Gastroenterol. 2013;19:5565–5574.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Selinger CP, Ramesh J, Martin DF. Long-term success of colonic stent insertion is influenced by indication but not by length of stent or site of obstruction. Int J Colorectal Dis. 2011;26:215–218.CrossRefPubMed Selinger CP, Ramesh J, Martin DF. Long-term success of colonic stent insertion is influenced by indication but not by length of stent or site of obstruction. Int J Colorectal Dis. 2011;26:215–218.CrossRefPubMed
3.
Zurück zum Zitat Okafor PN, Stobaugh DJ, Song LMWK, Limburg PJ, Talwalkar JA. Socioeconomic inequalities in the utilization of colorectal stens for the treatment of malignant bowel obstruction. Dig Dis Sci. (Epub ahead of print). doi:10.1007/s10620-015-4019-8 Okafor PN, Stobaugh DJ, Song LMWK, Limburg PJ, Talwalkar JA. Socioeconomic inequalities in the utilization of colorectal stens for the treatment of malignant bowel obstruction. Dig Dis Sci. (Epub ahead of print). doi:10.​1007/​s10620-015-4019-8
4.
Zurück zum Zitat Patkar V, Acosta D, Davidson T, Jones A, Fox J, Keshtgar M. Cancer multidisciplinary team meetings: evidence, challenges, and the role of clinical decision support technology. Int J Breast Cancer. 2011;2011:831605.CrossRefPubMedPubMedCentral Patkar V, Acosta D, Davidson T, Jones A, Fox J, Keshtgar M. Cancer multidisciplinary team meetings: evidence, challenges, and the role of clinical decision support technology. Int J Breast Cancer. 2011;2011:831605.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Burton S, Brown G, Daniels IR, et al. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer. 2006;94:351–357.CrossRefPubMedPubMedCentral Burton S, Brown G, Daniels IR, et al. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer. 2006;94:351–357.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Robbins AS, Siegel RL, Jemal A. Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol. 2012;30:401–405.CrossRefPubMed Robbins AS, Siegel RL, Jemal A. Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol. 2012;30:401–405.CrossRefPubMed
7.
Zurück zum Zitat Fitzgerald TL, Bradley CJ, Dahman B, Zervos EE. Gastrointestinal malignancies: When does race matter? J Am Coll Surg. 2009;209:645–652.CrossRefPubMed Fitzgerald TL, Bradley CJ, Dahman B, Zervos EE. Gastrointestinal malignancies: When does race matter? J Am Coll Surg. 2009;209:645–652.CrossRefPubMed
8.
Zurück zum Zitat Davies RJ, Miller R, Coleman N. Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer. 2005;5:199–209.CrossRefPubMed Davies RJ, Miller R, Coleman N. Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer. 2005;5:199–209.CrossRefPubMed
9.
Zurück zum Zitat Palmer CK, Thomas MC, von Wagner C, Raine R. Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: a qualitative study. Br J Cancer. 2014;110:1705–1711.CrossRefPubMedPubMedCentral Palmer CK, Thomas MC, von Wagner C, Raine R. Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: a qualitative study. Br J Cancer. 2014;110:1705–1711.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat van Hooft JE, van Halsema EE, Vanbiervliet G, et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2014;46:990–1053.CrossRefPubMed van Hooft JE, van Halsema EE, Vanbiervliet G, et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2014;46:990–1053.CrossRefPubMed
Metadaten
Titel
SEMS for Palliation of Malignant Colonic Obstruction: Why SEMi Available Is Not Good Enough
verfasst von
Christian P. Selinger
Publikationsdatum
10.02.2016
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 7/2016
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4070-0

Weitere Artikel der Ausgabe 7/2016

Digestive Diseases and Sciences 7/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.